• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过增强蛋白酶体活性,利用USP14适配体促进tau蛋白降解。

Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity.

作者信息

Lee Jung Hoon, Shin Seung Kyun, Jiang Yanxialei, Choi Won Hoon, Hong Chaesun, Kim Dong-Eun, Lee Min Jae

机构信息

Department of Biochemistry and Molecular Biology, Neuroscience Research Institute, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea.

Department of Applied Chemistry, College of Applied Sciences, Kyung Hee University, Yongin 446-701, Republic of Korea.

出版信息

Sci Rep. 2015 Jun 4;5:10757. doi: 10.1038/srep10757.

DOI:10.1038/srep10757
PMID:26041011
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4455164/
Abstract

The ubiquitin-proteasome system (UPS) is the primary mechanism by which intracellular proteins, transcription factors, and many proteotoxic proteins with aggregation-prone structures are degraded. The UPS is reportedly downregulated in various neurodegenerative disorders, with increased proteasome activity shown to be beneficial in many related disease models. Proteasomes function under tonic inhibitory conditions, possibly via the ubiquitin chain-trimming function of USP14, a proteasome-associated deubiquitinating enzyme (DUB). We identified three specific RNA aptamers of USP14 (USP14-1, USP14-2, and USP14-3) that inhibited its deubiquitinating activity. The nucleotide sequences of these non-cytotoxic USP14 aptamers contained conserved GGAGG motifs, with G-rich regions upstream, and similar secondary structures. They efficiently elevated proteasomal activity, as determined by the increased degradation of small fluorogenic peptide substrates and physiological polyubiquitinated Sic1 proteins. Additionally, proteasomal degradation of tau proteins was facilitated in the presence of the UPS14 aptamers in vitro. Our results indicate that these novel inhibitory UPS14 aptamers can be used to enhance proteasome activity, and to facilitate the degradation of proteotoxic proteins, thereby protecting cells from various neurodegenerative stressors.

摘要

泛素-蛋白酶体系统(UPS)是细胞内蛋白质、转录因子以及许多具有易于聚集结构的蛋白毒性蛋白被降解的主要机制。据报道,UPS在各种神经退行性疾病中下调,在许多相关疾病模型中,蛋白酶体活性增加显示出有益作用。蛋白酶体在强直性抑制条件下起作用,可能是通过蛋白酶体相关去泛素化酶(DUB)USP14的泛素链修剪功能。我们鉴定出了USP14的三种特异性RNA适配体(USP14-1、USP14-2和USP14-3),它们抑制了USP14的去泛素化活性。这些无细胞毒性的USP14适配体的核苷酸序列包含保守的GGAGG基序,其上游有富含G的区域,并且具有相似的二级结构。通过小荧光肽底物和生理性多聚泛素化Sic1蛋白降解增加来测定,它们能有效提高蛋白酶体活性。此外,在体外存在USP14适配体的情况下,tau蛋白的蛋白酶体降解得到促进。我们的结果表明,这些新型抑制性USP14适配体可用于增强蛋白酶体活性,并促进蛋白毒性蛋白的降解,从而保护细胞免受各种神经退行性应激源的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/8902845ba496/srep10757-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/1581a90d0fa8/srep10757-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/cac59bb29b29/srep10757-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/9995ca998579/srep10757-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/8902845ba496/srep10757-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/1581a90d0fa8/srep10757-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/cac59bb29b29/srep10757-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/9995ca998579/srep10757-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a76/4455164/8902845ba496/srep10757-f4.jpg

相似文献

1
Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity.通过增强蛋白酶体活性,利用USP14适配体促进tau蛋白降解。
Sci Rep. 2015 Jun 4;5:10757. doi: 10.1038/srep10757.
2
Isolation and Characterization of RNA Aptamers against a Proteasome-Associated Deubiquitylating Enzyme UCH37.针对蛋白酶体相关去泛素化酶UCH37的RNA适配体的分离与鉴定
Chembiochem. 2017 Jan 17;18(2):171-175. doi: 10.1002/cbic.201600515. Epub 2016 Dec 8.
3
The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis.去泛素化酶Usp14通过变构作用抑制多种蛋白酶体活性和不依赖泛素的蛋白水解作用。
J Biol Chem. 2017 Jun 9;292(23):9830-9839. doi: 10.1074/jbc.M116.763128. Epub 2017 Apr 17.
4
Ubiquitinated proteins promote the association of proteasomes with the deubiquitinating enzyme Usp14 and the ubiquitin ligase Ube3c.泛素化蛋白促进蛋白酶体与去泛素化酶Usp14和泛素连接酶Ube3c的结合。
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):E3404-E3413. doi: 10.1073/pnas.1701734114. Epub 2017 Apr 10.
5
In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.蛋白酶体相关的USP14活性对底物降解和去泛素化的体外分析。
Methods Enzymol. 2019;619:249-268. doi: 10.1016/bs.mie.2018.12.028. Epub 2019 Feb 1.
6
Enhancement of proteasome activity by a small-molecule inhibitor of USP14.小分子抑制剂 USP14 对蛋白酶体活性的增强作用。
Nature. 2010 Sep 9;467(7312):179-84. doi: 10.1038/nature09299.
7
Inactivation of USP14 Perturbs Ubiquitin Homeostasis and Delays the Cell Cycle in Mouse Embryonic Fibroblasts and in Fruit Fly Drosophila.USP14 的失活扰乱泛素稳态并延迟小鼠胚胎成纤维细胞和果蝇中的细胞周期。
Cell Physiol Biochem. 2018;47(1):67-82. doi: 10.1159/000489750. Epub 2018 May 9.
8
An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.蛋白酶体去泛素化酶USP14的抑制剂可诱导培养神经元中tau蛋白的清除。
J Biol Chem. 2017 Nov 24;292(47):19209-19225. doi: 10.1074/jbc.M117.815126. Epub 2017 Sep 26.
9
Ubiquitin-specific protease 14 regulates c-Jun N-terminal kinase signaling at the neuromuscular junction.泛素特异性蛋白酶14在神经肌肉接头处调节c-Jun氨基末端激酶信号通路。
Mol Neurodegener. 2015 Jan 10;10:3. doi: 10.1186/1750-1326-10-3.
10
UBL domain of Usp14 and other proteins stimulates proteasome activities and protein degradation in cells.Usp14 和其他蛋白质的 UBL 结构域可刺激细胞内蛋白酶体的活性和蛋白质降解。
Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11642-E11650. doi: 10.1073/pnas.1808731115. Epub 2018 Nov 28.

引用本文的文献

1
AKT and DUBs: a bidirectional relationship.AKT与去泛素化酶:一种双向关系。
Cell Mol Biol Lett. 2025 Jul 7;30(1):77. doi: 10.1186/s11658-025-00753-3.
2
Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities.阿尔茨海默病中tau蛋白的降解:机制与治疗机遇
Alzheimers Dement. 2025 Mar;21(3):e70048. doi: 10.1002/alz.70048.
3
YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease.YOD1通过去泛素化MYH9调节小胶质细胞内稳态,以促进阿尔茨海默病的发病机制。

本文引用的文献

1
Direct cellular delivery of human proteasomes to delay tau aggregation.直接向细胞内递送人蛋白酶体以延缓 tau 聚集。
Nat Commun. 2014 Dec 5;5:5633. doi: 10.1038/ncomms6633.
2
Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling.USP14 对 Dishevelled 的去泛素化修饰是 Wnt 信号通路所必需的。
Oncogenesis. 2013 Aug 19;2(8):e64. doi: 10.1038/oncsis.2013.28.
3
Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system.tau 降解:泛素-蛋白酶体系统与自噬溶酶体系统。
Acta Pharm Sin B. 2025 Jan;15(1):331-348. doi: 10.1016/j.apsb.2024.11.020. Epub 2024 Nov 26.
4
Deubiquitinases as novel therapeutic targets for diseases.去泛素化酶作为疾病的新型治疗靶点。
MedComm (2020). 2024 Dec 13;5(12):e70036. doi: 10.1002/mco2.70036. eCollection 2024 Dec.
5
miR-26a-5p Attenuates Oxidative Stress and Inflammation in Diabetic Retinopathy through the USP14/NF-B Signaling Pathway.miR-26a-5p通过USP14/NF-κB信号通路减轻糖尿病视网膜病变中的氧化应激和炎症反应。
J Ophthalmol. 2024 Jan 19;2024:1470898. doi: 10.1155/2024/1470898. eCollection 2024.
6
Polymorphic USP8 allele promotes Parkinson's disease by inducing the accumulation of α-synuclein through deubiquitination.多态性 USP8 等位基因通过去泛素化诱导α-突触核蛋白积累促进帕金森病。
Cell Mol Life Sci. 2023 Nov 19;80(12):363. doi: 10.1007/s00018-023-05006-0.
7
DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases.DUBing 原发性中枢神经系统肿瘤:去泛素化酶的调控作用。
Biomolecules. 2023 Oct 10;13(10):1503. doi: 10.3390/biom13101503.
8
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women.X 连锁泛素特异性肽酶 11 增加女性 tau 病易感性。
Cell. 2022 Oct 13;185(21):3913-3930.e19. doi: 10.1016/j.cell.2022.09.002. Epub 2022 Oct 4.
9
Research Progress of DUB Enzyme in Hepatocellular Carcinoma.去泛素化酶在肝细胞癌中的研究进展
Front Oncol. 2022 Jun 27;12:920287. doi: 10.3389/fonc.2022.920287. eCollection 2022.
10
USP14: Structure, Function, and Target Inhibition.USP14:结构、功能及靶点抑制
Front Pharmacol. 2022 Jan 5;12:801328. doi: 10.3389/fphar.2021.801328. eCollection 2021.
Prog Neurobiol. 2013 Jun;105:49-59. doi: 10.1016/j.pneurobio.2013.03.001. Epub 2013 Mar 23.
4
In vivo SELEX for Identification of Brain-penetrating Aptamers.体内 SELEX 技术用于鉴定脑穿透适体。
Mol Ther Nucleic Acids. 2013 Jan 8;2(1):e67. doi: 10.1038/mtna.2012.59.
5
Functions of the 19S complex in proteasomal degradation.19S 复合物在蛋白酶体降解中的功能。
Trends Biochem Sci. 2013 Feb;38(2):103-10. doi: 10.1016/j.tibs.2012.11.009. Epub 2013 Jan 2.
6
Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice.增强蛋白酶体功能可预防小鼠心脏蛋白病变和缺血/再灌注损伤。
J Clin Invest. 2011 Sep;121(9):3689-700. doi: 10.1172/JCI45709. Epub 2011 Aug 15.
7
Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.PA28α过表达增强蛋白酶体功能可抵御氧化应激。
FASEB J. 2011 Mar;25(3):883-93. doi: 10.1096/fj.10-160895. Epub 2010 Nov 23.
8
Enhancement of proteasome activity by a small-molecule inhibitor of USP14.小分子抑制剂 USP14 对蛋白酶体活性的增强作用。
Nature. 2010 Sep 9;467(7312):179-84. doi: 10.1038/nature09299.
9
Trimming of ubiquitin chains by proteasome-associated deubiquitinating enzymes.蛋白酶体相关去泛素化酶对泛素链的修剪。
Mol Cell Proteomics. 2011 May;10(5):R110.003871. doi: 10.1074/mcp.R110.003871. Epub 2010 Sep 7.
10
Aptamers as therapeutics.适配子疗法。
Nat Rev Drug Discov. 2010 Jul;9(7):537-50. doi: 10.1038/nrd3141.